Market research reports, consulting: Global Market Insights Inc.
We use cookies to enhance user experience. (Privacy Policy)

Central Lab Market Trends

Report ID: GMI10831
   |
Published Date: August 2024
 | 
Report Format: PDF

Download free sample

Central Lab Market Trends

Advancements like enhanced capabilities in next-generation sequencing (NGS), automated lab systems, AI and machine learning, point-of-care testing innovations, and advanced biosensors are elevating the precision, efficiency, and scope of lab services.

 

  • NGS technology allows for comprehensive analysis of genetic material, providing detailed insights into genetic disorders, cancers, and other diseases. It offers high-throughput capabilities that can process vast amounts of genetic data quickly and accurately.
     
  • Additionally, automation in laboratories involves the use of robotic systems and automated analyzers to perform routine tasks such as sample handling, testing, and result analysis. This reduces human error, increases throughput, and enhances reproducibility.
     
  • Furthermore, the incorporation of POCT technologies enables rapid testing at the patient’s location, providing immediate results that can be used for timely decision-making. Innovations in POCT devices are making them more portable, accurate, and user-friendly.
     
  • Moreover, recent advancements include more sensitive and specific biosensor for detecting a wide range of biomarkers and pathogens. These technologies enhance testing efficiency, accuracy, and capabilities, making central labs crucial for modern healthcare and research.
Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
Who are the major central lab industry players?
A.P. Moller Holding A/S, ACM Global Laboratories, BioAgilytix Labs, Cerba Research, Cirion Biopharma Research Inc., Covance Inc., Eurofins Scientific, Frontage Laboratories, ICON Central Laboratories, and LabConnect, among others.
Why is the central lab industry booming in North America?
Why is the use of central labs rising in biomarker services?
How big is the central lab market?

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definition

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Growing emphasis on outsourcing of testing services

3.2.1.2    Technological advancements in testing equipment

3.2.1.3    Extensive growth in research and development investments

3.2.2    Industry pitfalls & challenges

3.2.2.1    Stringent government regulations and compliance

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Technological landscape

3.6    Porter's analysis

3.7    PESTEL analysis

3.8    Future market trends

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company matrix analysis

4.3    Competitive analysis of major market players

4.4    Competitive positioning matrix

4.5    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Services, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Genetic services

5.3    Biomarker services

5.4    Microbiology services

5.5    Anatomic pathology/histology

5.6    Specimen management & storage

5.7    Other services

Chapter 6   Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Oncology

6.3    Neurology

6.4    Cardiology

6.5    Infectious diseases

6.6    Other applications

Chapter 7   Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Pharmaceutical and biotechnology companies

7.3    Academic and research institutes

7.4    Other end-users

Chapter 8   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Italy

8.3.5    Spain

8.3.6    Netherlands

8.3.7    Rest of Europe

8.4    Asia Pacific

8.4.1    China

8.4.2    Japan

8.4.3    India

8.4.4    Australia

8.4.5    South Korea

8.4.6    Rest of Asia Pacific

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Argentina

8.5.4    Rest of Latin America

8.6    Middle East and Africa

8.6.1    Saudi Arabia

8.6.2    South Africa

8.6.3    UAE

8.6.4    Rest of Middle East and Africa

Chapter 9   Company Profiles

9.1    A.P. Moller Holding A/S

9.2    ACM Global Laboratories

9.3    BioAgilytix Labs

9.4    Cerba Research

9.5    Cirion Biopharma Research Inc.

9.6    Covance Inc.

9.7    Eurofins Scientific

9.8    Frontage Laboratories

9.9    ICON Central Laboratories

9.10    LabConnect

9.11    Laboratory Corporation of America Holding

9.12    Lambda Therapeutics Research Ltd

9.13    Medpace, Inc.

9.14    Parexel International Corporation

9.15    Quest Diagnostics

9.16    Versiti

Authors: Mariam Faizullabhoy, Gauri Wani
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
    Buy now
Premium Report Details

Base Year: 2023

Companies covered: 16

Tables & Figures: 121

Countries covered: 23

Pages: 110

Download Free Sample

Top